The relationship between NAFLD and retinol-binding protein 4-an updated systematic review and meta-analysis

被引:6
作者
Hu, Rui [1 ,2 ]
Yang, Xiaoyue [1 ,2 ]
He, Xiaoyu [1 ,2 ]
Song, Guangyao [2 ]
机构
[1] Hebei Med Univ, Dept Internal Med, Shijiazhuang 050017, Hebei, Peoples R China
[2] Hebei Gen Hosp, Endocrinol Dept, Shijiazhuang 050051, Hebei, Peoples R China
关键词
Non-alcoholic fatty liver disease; RBP4; protein; human; meta-analysis; Systematic review; FATTY LIVER-DISEASE; SERUM RETINOL-BINDING-PROTEIN-4; INSULIN-RESISTANCE; ASSOCIATION; OBESITY; FIBROSIS; HEALTH; WOMEN;
D O I
10.1186/s12944-022-01771-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PurposeRetinol-binding protein 4 (RBP4) has been considered to be related to metabolic related diseases, such as hyperuricemia, obesity, and diabetes mellitus. However, whether nonalcoholic fatty liver disease (NAFLD) is related to RBP4 is unclear. Previous studies on the relationship between NAFLD and RBP4 levels have yielded inconsistent results. Hence, this meta-analysis was aimed to clarify whether circulating RBP4 levels are in relation to the risk of NAFLD.MethodsA meta-analysis was performed by applying observational studies to evaluate circulating RBP4 levels and NAFLD. Eligible studies published up to September 23, 2022, were searched in Embase, PubMed, and Cochrane databases.ResultsIn this study, 17 cross-sectional studies involving 8423 participants were included. Results from a random effects model showed that circulating RBP4 levels were higher in NAFLD patients than non-NAFLD (standardized mean difference (SMD) 0.28; 95% confidence intervals (CI): 0.11-0.46, I-2: 89.8%). This association was confirmed in the Yellow race. However, no significant association was noted in the Caucasian race. After excluding the morbidly obese Population from the weight loss study (n = 2), the results of the comparison remained largely unchanged (SMD 0.28; 95% CI: 0.10-0.47, I-2: 90.8%). Remarkable publication bias was not found. Although considerable heterogeneity was observed among the studies, no potential sources of heterogeneity were found in the subgroup analysis. Diagnostic methods for NAFLD were determined to be a potential source of statistical heterogeneity in meta-regression.ConclusionThe findings provide evidence that NAFLD patients exhibit higher levels of circulating RBP4 compared with controls, but high heterogeneity was observed. Thus, a high RBP4 level is probably a potential risk factor for NAFLD. To confirm the causal link between NAFLD and RBP4 level of causality, further prospective cohort studies are needed.
引用
收藏
页数:13
相关论文
共 47 条
  • [1] The natural history of nonalcoholic fatty liver disease: A population-based cohort study
    Adams, LA
    Lymp, JF
    St Sauver, J
    Sanderson, SO
    Lindor, KD
    Feldstein, A
    Angulo, P
    [J]. GASTROENTEROLOGY, 2005, 129 (01) : 113 - 121
  • [2] Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih, Mohamed
    Jornayvaz, Francois R.
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2015, 418 : 55 - 65
  • [3] Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease
    Auguet, Teresa
    Terra, Ximena
    Porras, Jose Antonio
    Maria Orellana-Gavalda, Josep
    Martinez, Salome
    Aguilar, Carmen
    Lucas, Anna
    Pellitero, Silvia
    Hernandez, Merce
    Del Castillo, Daniel
    Richart, Cristobal
    [J]. CLINICAL BIOCHEMISTRY, 2013, 46 (03) : 202 - 208
  • [4] Ballestri S., 2016, J GASTROEN HEPATOL, V31, P936
  • [5] Adipose Tissue Dysregulation in Patients with Metabolic Syndrome
    Bremer, Andrew A.
    Devaraj, Sridevi
    Afify, Alaa
    Jialal, Ishwarlal
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (11) : E1782 - E1788
  • [6] The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
    Buzzetti, Elena
    Pinzani, Massimo
    Tsochatzis, Emmanuel A.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1038 - 1048
  • [7] Serum retinol binding protein 4 and galectin-3 binding protein as novel markers for postmenopausal nonalcoholic fatty liver disease
    Cai, Hong
    Lu, Sha
    Chen, Yueming
    Das, Sayantana
    Niu, Zheng
    Zhuo, Guangchao
    Lai, Lei
    Zhang, Zhifen
    [J]. CLINICAL BIOCHEMISTRY, 2018, 56 : 95 - 101
  • [8] Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?
    Cengiz, Cem
    Ardicoglu, Yasemin
    Bulut, Safak
    Boyacioglu, Sedat
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (07) : 813 - 819
  • [9] Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans
    Chavez, Alberto O.
    Coletta, Dawn K.
    Kamath, Subhash
    Cromack, Douglas T.
    Monroy, Adriana
    Folli, Franco
    DeFronzo, Ralph A.
    Tripathy, Devjit
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2009, 296 (04): : E758 - E764
  • [10] Retinol Binding Protein-4 Levels and Non-alcoholic Fatty Liver Disease: A community-based cross-sectional study
    Chen, Xuechen
    Shen, Tianran
    Li, Qing
    Chen, Xu
    Li, Yanping
    Li, Dan
    Chen, Gengdong
    Ling, Wenhua
    Chen, Yu-ming
    [J]. SCIENTIFIC REPORTS, 2017, 7